Related Experiment Video

Updated: May 26, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Personalized therapy in endometrial cancer: challenges and opportunities

Shannon N Westin1, Russell R Broaddus

  • 1Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cancer Biology & Therapy
|December 27, 2011
PubMed

Insights

Targeted therapy offers new hope for advanced endometrial cancer by focusing on specific molecular alterations. Personalized treatment requires detailed tumor characterization for maximum effectiveness.

Area of Science:

  • Gynecologic Oncology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Early-stage endometrial cancer is curable, but advanced and recurrent forms have limited treatment options.
  • Traditional chemotherapy and radiotherapy show limited progress in advanced endometrial cancer.
  • Endometrial cancer harbors numerous druggable molecular alterations, prompting a shift towards targeted therapy.

Purpose of the Study:

  • To review key molecular pathways for targeted therapy in endometrial cancer.
  • To discuss the challenges in developing personalized oncology approaches for endometrial cancer.
  • To highlight the necessity of molecular characterization for effective targeted therapy.

Main Methods:

  • Literature review of targeted therapy in endometrial cancer.
  • Analysis of molecular alterations and relevant pathways.
  • Discussion of challenges in personalized treatment development.

Main Results:

  • Targeted therapy represents a promising approach for advanced and recurrent endometrial cancer.
  • Molecular characterization of tumors is crucial for maximizing targeted therapy efficacy.
  • Personalized oncology requires a shift from traditional treatment modalities.

Conclusions:

  • Targeted therapy, guided by molecular profiling, is a key strategy for improving outcomes in advanced endometrial cancer.
  • Overcoming challenges in personalized treatment development is essential for clinical success.
  • Understanding druggable targets is critical for advancing endometrial cancer care.

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...